IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by abrdn plc
IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent ...
IQVIA Holdings Inc. (NYSE:IQV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars
Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on ...
IQVIA beats quarterly results estimates on analytics services demand
Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.
IQVIA sees 2025 revenue growth of 4%-7% amid strong demand recovery
Q4 2024. Management View. CEO Ari Bousbib highlighted that IQVIA achieved solid revenue growth of 5.5% at constant currency ...
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...
Iqvia price target raised to $220 from $210 at Baird
Baird raised the firm’s price target on Iqvia (IQV) to $220 from $210 and keeps a Neutral rating on the shares. The firm updated its model ...
IQVIA (NYSE:IQV) Cut to “Neutral” at BTIG Research
BTIG Research lowered shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com reports. Several other ...
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...